{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:29:10Z","timestamp":1785461350126,"version":"3.56.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Melioidosis, caused by Burkholderia pseudomallei, is a deadly infection with a case fatality rate of 10%\u201350%. Osteomyelitis, a rare manifestation, is particularly challenging due to diagnostic delays, misidentification, limited bone penetration of antibiotics and frequent relapses. Antibiotic intolerance emerges as a significant hurdle, with up to 26%\u201351% of patients developing severe allergies to trimethoprim\/sulfamethoxazole, along with intolerability to ceftazidime and meropenem. These limitations demand innovative therapeutic approaches to combat this pathogen.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To report a novel case of B. pseudomallei-induced radial osteomyelitis successfully managed with levonadifloxacin, a broad-spectrum benzoquinolizine antibiotic, after intolerance to the conventional therapies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A 59-year-old man presented with radial osteomyelitis requiring multiple rounds of surgical debridement. Severe allergic reactions to trimethoprim\/sulfamethoxazole and ceftazidime, and meropenem-associated leukopenia made traditional therapies unfeasible. Levonadifloxacin was introduced as a salvage therapy, leveraging its efficacy against B. pseudomallei, favourable bone penetration, antibiofilm activity and tolerability. The patient received IV levonadifloxacin for 5\u2005days, followed by almost 8\u2005months of its oral prodrug, alalevonadifloxacin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Levonadifloxacin emerged as the salvage therapy for this patient, achieving significant clinical improvement without relapse after more than 6\u2005months of therapy cessation, despite the life-threatening combination of melioidosis-associated osteomyelitis and antibiotic intolerance. This first reported use of levonadifloxacin in melioidosis underscores its potential as an alternative therapy in such complex infections. Aggressive surgical intervention and tailored antimicrobial strategies remain crucial to overcoming these dual challenges.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlaf122","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:59:20Z","timestamp":1751443160000},"source":"Crossref","is-referenced-by-count":2,"title":["Novel approach in treatment of <i>Burkholderia pseudomallei<\/i> osteomyelitis: salvage therapy with levonadifloxacin"],"prefix":"10.1093","volume":"7","author":[{"given":"Neha","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, NG Swastha and Fortis Memorial Research Institute , Gurugram ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Agashe","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, P. D. Hinduja and Agashe Hospital , Mumbai ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Soman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Jupiter Hospital , Pune ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandarp","family":"Vidyarthi","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Paras Hospitals , Gurugram ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medanta, The Medicity , Gurugram ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Sen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Fortis Memorial Research Institute , Gurgaon ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinalini","family":"Koley","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Fortis Memorial Research Institute , Gurgaon ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Christian Medical College , Vellore ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Gupta","sequence":"additional","affiliation":[{"name":"General Surgeon, Teerath Nursing Home , Rewa, Madhya Pradesh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"2025071704414783000_dlaf122-B1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1086\/318116","article-title":"Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature","volume":"31","author":"Currie","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2025071704414783000_dlaf122-B2","doi-asserted-by":"publisher","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","article-title":"Melioidosis","volume":"4","author":"Wiersinga","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025071704414783000_dlaf122-B3","doi-asserted-by":"publisher","first-page":"107283","DOI":"10.1016\/j.ijid.2024.107283","article-title":"Adverse reactions to trimethoprim\/sulfamethoxazole for melioidosis eradication therapy: an evaluation of frequency and risk factors","volume":"150","author":"Martin","year":"2025","journal-title":"Int J Infect Dis"},{"key":"2025071704414783000_dlaf122-B4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"2025071704414783000_dlaf122-B5","author":"Gupta"},{"key":"2025071704414783000_dlaf122-B6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3201\/eid0601.000110","article-title":"Burkholderia pseudomallei traced to water treatment plant in Australia","volume":"6","author":"Inglis","year":"2000","journal-title":"Emerging Infect Dis"},{"key":"2025071704414783000_dlaf122-B7","doi-asserted-by":"publisher","first-page":"100004","DOI":"10.1016\/j.lansea.2022.03.004","article-title":"Burden of melioidosis in India and South Asia: challenges and ways forward","volume":"2","author":"Mohapatra","year":"2022","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"2025071704414783000_dlaf122-B8","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3201\/eid1707.100614","article-title":"Burkholderia pseudomallei in unchlorinated domestic bore water, tropical northern Australia","volume":"7","author":"Mayo","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2025071704414783000_dlaf122-B9","volume-title":"Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria\u2014Third Edition: M45","author":"CLSI"},{"key":"2025071704414783000_dlaf122-B10","doi-asserted-by":"publisher","first-page":"101431","DOI":"10.1016\/j.cegh.2023.101431","article-title":"In vitro activity of levonadifloxacin, the active drug of orally administered prodrug alalevonadifloxacin against bloodstream isolates of Burkholderia pseudomallei","volume":"26","author":"Bakthavatchalam","year":"2024","journal-title":"Clin Epidemiol Glob Health"},{"key":"2025071704414783000_dlaf122-B11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1099\/jmm.0.000999","article-title":"In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms","volume":"68","author":"Tellis","year":"2019","journal-title":"J Med Microbiol"},{"key":"2025071704414783000_dlaf122-B12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/mdr.2024.0118","article-title":"Serum pharmacokinetics and bone penetration of novel broad-spectrum anti-MRSA agent levonadifloxacin in Wistar rats","volume":"30","author":"Chavan","year":"2024","journal-title":"Microb Drug Resist"},{"key":"2025071704414783000_dlaf122-B13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/tropicalmed3020051","article-title":"Melioidosis in South Asia (India, Nepal, Pakistan, Bhutan and Afghanistan)","volume":"3","author":"Mukhopadhyay","year":"2018","journal-title":"Tropic Med and Infect Dis"},{"key":"2025071704414783000_dlaf122-B14","doi-asserted-by":"publisher","first-page":"e02040","DOI":"10.1016\/j.idcr.2024.e02040","article-title":"Shoulder shake-up: unveiling the unusual case of acute melioidosis","volume":"37","author":"Khatod","year":"2024","journal-title":"IDCases"},{"key":"2025071704414783000_dlaf122-B15","first-page":"30","article-title":"Efficacy and safety of a novel broad-spectrum anti-MRSA agent levonadifloxacin compared with linezolid for acute bacterial skin and skin structure infections: a phase 3, openlabel, randomized study","volume":"68","author":"Bhatia","year":"2020","journal-title":"J Assoc Physicians India"},{"key":"2025071704414783000_dlaf122-B16","doi-asserted-by":"publisher","first-page":"e02297-17","DOI":"10.1128\/aac.02297-17","article-title":"Intrapulmonary pharmacokinetics of levonadifloxacin following oral administration of alalevonadifloxacin to healthy adult subjects","volume":"62","author":"Rodvold","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025071704414783000_dlaf122-B17","doi-asserted-by":"publisher","first-page":"100528","DOI":"10.1016\/j.ijmmb.2024.100528","article-title":"Treatment challenges in the management of difficult-to-treat gram-positive infections: a consensus view apropos therapeutic role of novel anti-MRSA antibiotics, levonadifloxacin (IV) and alalevonadifloxacin (oral)","volume":"47","author":"Saseedharan","year":"2024","journal-title":"Indian J Med Microbiol"},{"key":"2025071704414783000_dlaf122-B18","doi-asserted-by":"publisher","first-page":"e0008659","DOI":"10.1371\/journal.pntd.0008659","article-title":"2020 review and revision of the 2015 Darwin melioidosis treatment guideline; paradigm drift not shift","volume":"14","author":"Sullivan","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2025071704414783000_dlaf122-B19","doi-asserted-by":"publisher","first-page":"e3627","DOI":"10.1093\/cid\/ciaa1084","article-title":"A comparison between 12 versus 20 weeks of trimethoprim\/sulfamethoxazole as oral eradication treatment for melioidosis: an open-label, pragmatic, multicenter, non-inferiority, randomized controlled trial","volume":"73","author":"Anunnatsiri","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025071704414783000_dlaf122-B20","volume-title":"UpToDate","author":"Currie","year":"2023"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/4\/dlaf122\/63706586\/dlaf122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/4\/dlaf122\/63706586\/dlaf122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T08:41:55Z","timestamp":1752741715000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlaf122\/8194281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlaf122","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,2]]},"article-number":"dlaf122"}}